biosimilar biological product development meeting

(5) The term “biosimilar biological product development meeting” means any meeting, other than a biosimilar initial advisory meeting, regarding the content of a development program, including a proposed design for, or data from, a study intended to support a biosimilar biological product application.

Source

21 USC § 379j-51(5)


Scoping language

None identified. Default scope is assumed to be the entire title.
Is this correct? or